Pricing drugs: The WHA resolution brings some transparency to drug pricing but full disclosure of R&D costs is still not available to consumers. — Filepic
THE 72nd World Health Assembly (WHA) on Tuesday adopted a resolution that will make the pricing of medicines more transparent.
Critics, however, deem the resolution a weaker, watered down version of the original draft that had been sparked by concern that pharmaceutical companies have been setting prices so high that some life-saving drugs are beyond the reach of many (“Pricey problems with medicine”, Sunday Star, May 19; online at bit.ly/star_
